We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Cytokinetics
CYTK
$10.2B
| $1.6M | 0.01% |
49,088
+6,111
| +14% | +$226K |
|
1027
Moelis & Co
MC
$4.91B
| $1.6M | 0.01% |
35,269
+1,729
| +5% | +$69K |
|
1028
NewMarket
NEU
$8.72B
| $1.6M | 0.01% |
3,973
-113
| -3% | -$44.1K |
|
|
SEE
1029
DELISTED
Sealed Air
SEE
| $1.6M | 0.01% |
39,940
-3,224
| -7% | -$137K |
|
1030
BlackLine
BL
$1.82B
| $1.58M | 0.01% |
29,442
+492
| +2% | +$27.3K |
|
1031
Flywire
FLYW
$2.22B
| $1.58M | 0.01% |
50,828
+21,176
| +71% | +$635K |
|
1032
Prestige Consumer Healthcare
PBH
$2.43B
| $1.57M | 0.01% |
26,351
+316
| +1% | +$18.9K |
|
1033
Avista
AVA
$3.23B
| $1.54M | 0.01% |
39,341
+683
| +2% | +$29K |
|
1034
DXC Technology
DXC
$1.79B
| $1.54M | 0.01% |
57,773
-1,028
| -2% | -$25.6K |
|
1035
Signet Jewelers
SIG
$3.59B
| $1.54M | 0.01% |
23,652
| – | – |
|
1036
Integer Holdings
ITGR
$4.25B
| $1.54M | 0.01% |
17,373
+213
| +1% | +$17.4K |
|
1037
Albany International
AIN
$1.81B
| $1.54M | 0.01% |
16,503
| – | – |
|
|
ESGR
1038
DELISTED
Enstar Group
ESGR
| $1.54M | 0.01% |
6,298
+466
| +8% | +$115K |
|
1039
Shake Shack
SHAK
$2.94B
| $1.54M | 0.01% |
19,776
| – | – |
|
1040
Broadstone Net Lease
BNL
$4.31B
| $1.54M | 0.01% |
99,501
+6,178
| +7% | +$99K |
|
|
RETA
1041
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.54M | 0.01% |
15,065
+620
| +4% | +$58.7K |
|
|
ARNC
1042
DELISTED
Arconic Corporation
ARNC
| $1.53M | 0.01% |
51,859
-1,359
| -3% | -$37.5K |
|
1043
Cogent Communications
CCOI
$530M
| $1.53M | 0.01% |
22,767
+291
| +1% | +$19K |
|
|
RCM
1044
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.53M | 0.01% |
82,999
-78,077
| -48% | -$1.27M |
|
1045
Hamilton Lane
HLNE
$5.69B
| $1.53M | 0.01% |
19,142
+299
| +2% | +$21.5K |
|
1046
InMode
INMD
$876M
| $1.53M | 0.01% |
+40,987
| New | +$1.43M |
|
1047
Kohl's
KSS
$2.22B
| $1.53M | 0.01% |
66,362
-1,376
| -2% | -$29.8K |
|
1048
Acadia Pharmaceuticals
ACAD
$5.07B
| $1.53M | 0.01% |
63,755
| – | – |
|
|
UCB
1049
United Community Banks
UCB
$4.43B
| $1.53M | 0.01% |
61,033
+6,125
| +11% | +$152K |
|
|
GMS
1050
DELISTED
GMS Inc
GMS
| $1.52M | 0.01% |
21,971
| – | – |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.